For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250627:nRSa8240Oa&default-theme=true
RNS Number : 8240O MicroSalt PLC 27 June 2025
27 June 2025
MicroSalt Plc
("MicroSalt" or the "Company")
Result of AGM
MicroSalt plc, a leading manufacturer of full flavour salt with approximately
50% less sodium is pleased to announce that all resolutions proposed to
shareholders at its Annual General Meeting today were duly passed.
The total number of votes received in respect of all resolutions were as
follows:
For Against Votes Withheld Total votes cast
Number of Votes % Number of Votes %
Ordinary Resolutions
1. Approval of Annual Report and Accounts 34,823,571 99.96 15,264 0.04 103 34,838,835
2. To re-appointment Crowe U.K. LLP as Auditors 34,822,719 99.95 15,852 0.05 367 34,838,571
3. To authorise Directors to set Auditors remuneration 34,822,744 99.95 16,091 0.05 103 34,838,835
6. To re-elect Judith Batchelar as a Director 34,813,092 99.94 19,163 0.06 6,683 34,832,255
4. To re-elect Rick Guiney as a Director 34,819,303 99.94 19,163 0.06 472 34,838,466
5. To re-elect Konrad Dabrowski as a Director 34,818,715 99.94 19,751 0.06 472 34,838,466
7. To re-elect Gary Urmston as a Director 34,820,032 99.95 18,434 0.05 472 34,838,466
8. To re-elect Daniel Emery as a Director 34,821,246 99.95 17,220 0.05 472 34,838,466
9. Authority to Allot Shares 34,783,598 99.95 18,034 0.05 37,306 34,801,632
Special Resolution
10. Disapplication of pre-emption rights 34,788,116 99.94 19,358 0.06 31,464 34,807,474
Notes:
1. Proxy appointments which gave discretion to the Chairman of the AGM
have been included in the "For" total for the appropriate resolution.
2. Votes "For" and "Against" any resolution are expressed as a percentage
of votes validly cast for that resolution.
3. A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against".
4. The number of shares in issue on 27 June 2025 was 51,963,276.
5. The full text of the resolutions passed at the AGM can be found in the
Notice of Annual General Meeting which is available on the Company's website
at www.microsalt.co.
For further information, please visit MicroSalt's website
(https://microsaltinc.com/home-uk/) or contact:
MicroSalt plc Via Flagstaff PR
Rick Guiney, CEO
Zeus (Nominated Adviser and Broker) +44 (0)20 3829 5000
David Foreman / James Edis (Investment Banking)
Dom King (Corporate Broking), Rupert Woolfenden (Sales)
Flagstaff PR (Financial PR/IR) +44 (0)20 7129 1474
Tim Thompson / Alison Allfrey / Anna Probert
Notes to Editors
MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its
micron sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the UK £19 billion - if the average
salt intake was reduced by one gram per day, it has been estimated that 4,147
lives and £288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70 per cent. of the
typical person's sodium intake is hidden in processed foods.
Operational since 2018, MicroSalt uses a patent-protected technology which
helps create high barriers to entry within the reduced-sodium salt market. The
group has a US patent and 14 patent applications pending in other
jurisdictions globally.
The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGDZGZVDNVGKZM